Skip Navigation
Search Menu

Print This Page
Share this page: More

103.25 Organization Policy on Registration of Clinical Trials

June 2008

It is the policy of the Organization that all clinical trials shall be registered at  The definition of a clinical trial for purposes of this policy is “Any research study that prospectively assigns human participants or groups of humans to one or more health related interventions to evaluate the effects on health outcomes."  Health outcomes include any biomedical or health-related measures, including pharmacokinetic measures and adverse events.  This incorporates requirements imposed by the September, 2007 FDA Amendments Act, which affected new and ongoing trials as of January 25, 2008.  This policy additionally incorporates the International Committee of Medical Journal Editors (ICMJE) policy applying to all trials beginning enrollment on or after July 1, 2008.

The Johns Hopkins PI should consult with commercial sponsors to assure that posting of a trial is in accord with terms of the study contract.

Clinical trial registration information will be requested with the initial IRB application.  If the trial has not been registered at that time, the PI must confirm trial registration at the time a continuing review application is submitted.  The JHM IRBs may approve a continuing review application for a study that has not been registered, but OHSR staff will notify the Institutional Official (IO).  The IO will contact the PI to indicate that new enrollment may not proceed until the trial has been registered, or that the IO accepts the delay in registration due to extenuating circumstances.

For further information, please see the guidance on registration of clinical trials at .